Applying Global Health Advocacy to the COVID-19 Response
AVAC is using decades of experience with the HIV/AIDS epidemic to synthesize complex information, ensure meaningful community engagement, and implement smart, actionable biomedical prevention advocacy within the global COVID response.
Essential resources on COVID, HIV and global health
THE LATEST
Breaking the Bottlenecks to COVID-19 Vaccine Access identifies factors contributing to bottlenecks in the COVID-19 vaccine global supply
Ensuring community engagement in COVID R&D
THE LATEST
Essential Principles & Practices for GPP Compliance: Engaging stakeholders in biomedical research during the era of COVID-19
Taking action to demand equity and access
THE LATEST
Calling on the Biden Administration to Scale Up mRNA Vaccine Manufacturing Capacity
AVAC's weekly Pandemic Watch is a curated news digest on the latest pandemic prevention, preparedness, and response (PPPR) news and resources. (Previously called the COVID News Brief.) View the archive.
To mark the launch of Essential Principles & Practices for GPP Compliance: Engaging stakeholders in biomedical research during the era of COVID-19, AVAC hosted a webinar on Thursday, April 1, about the importance of GPP within COVID-research and beyond.
This two-pager profiles authorized vaccines with an emphasis on the “3 C’s” that have a significant impact on equitable access: cost, cold chain and manufacturing capacity.
This three-pager offers advocates an at-a-glance view of the funders, platforms, research phase and considerations for some of the front-runner candidates.
The Advocate’s Guide provides plain-language explanations of the necessary components for equitable COVID-19 vaccine access to help inform and support advocates.